At The Buffalo Neuroimaging Analysis Center (BNAC), we are committed to providing the most current and comprehensive imaging research regarding the needs of those patients suffering from neurological disorders.

On a daily basis, our state-of-the-art research facilities are being used by our top scientists to advance the understanding of the causes of Multiple Sclerosis, Parkinson’s and Alzheimer’s diseases as well as epilepsy, stroke and aging.  Our researchers use the most contemporary, state-of-the-art imaging equipment to investigate these neurologic pathologies.  Dr. Zivadinov has acquired extensive research experience in MS.  His accomplishments in this field include numerous awards from European and national neurological societies for his published articles, research studies and research fellowships.  Dr. Zivadinov received his Ph.D. in neurology from the University of Rijeka in 2002.  In 2003, he was appointed Associate Professor of Neurology at the University at Buffalo, State University of New York (SUNY), as well as Director of the Buffalo Neuroimaging Analysis Center and Executive Director of The New York State Multiple Sclerosis Consortium.

BNAC has authored numerous imaging peer-reviewed publications.  Our work has appeared in journals such as Radiology, Neuroimage, American Journal of Radiology, Journal Magnetic Resonance Imaging, Magnetic Resonance Medicine, Journal of Neuroimaging, Brain, Annals of Neurology, Neurology, Archives of Neurology, Journal of Neurology, Neurosurgery and Psychiatry, Journal of Neurology and Multiple Sclerosis.

BNAC’s research has been supported by the National Institutes of Health, National Science Foundation, Department of Defense, National Multiple Sclerosis Society, Teva Pharmaceuticals, Teva Neuroscience, Biogen Idec, Genzyme-Sanofi, EMD Serono, Bracco, Greatbatch, General Electric and Aspreva.  Additionally, we have been sponsored by other various foundations such as: Jog for the Jake, The Oishei Foundation, Direct MS, The Jacquemin Family, Flowers 4 MS as well as The Funicello and Bronfman Foundations.

BNAC is currently pursuing research studies on quantitative magnetic resonance, ultrasound and optic coherence tomography imaging findings in multiple sclerosis (MS), Parkinson’s and Alzheimer’s diseases as well as aging.  Our current interests also concentrate on therapeutic interventions, including strategies towards assessing neuroprotective efforts in neurodegenerative disorders, as well as venous function, genetic and the neuroepidemiology fields of these diseases.

We are looking forward to providing you with more data and possibly, study outcomes in the near future that can advance knowledge in the field.

Please see a video on Information Television Network, Inc. website Healthy Body, Healthy Mind called New Weapons to Fight Multiple Sclerosis featuring BNAC Director Dr. Robert Zivadinov.

New discoveries about MS progression from the thalamus, Buffalo, NY – March 22, 2013.

A growing body of research by multiple sclerosis (MS) investigators at the University at Buffalo and their international partners is providing powerful new evidence that the brain’s gray matter reflects important changes in the disease that could allow clinicians to diagnose earlier and better monitor and predict how the disease will progress.

Over the past three years, the UB researchers and their partners around the world, supported by an active fellowship program at UB’s Buffalo Neuroimaging Analysis Center, (BNAC) have published journal papers and given presentations demonstrating that the thalamus region, in particular, is key to a host of issues involving MS. Dr. Zivadinov and Dr. Benedict discuss some aspects of this research. To view the video click here.